Zinc protects against arsenic-induced apoptosis in a neuronal cell line, measured by DEVD-caspase activity

被引:29
作者
Milton, AG [1 ]
Zalewski, PD [1 ]
Ratnaike, RN [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Med, Woodville, SA 5011, Australia
关键词
arsenic trioxide; 2.3D mouse neuroepithelial cells; DEVD-caspase; zinc sulfate;
D O I
10.1007/s10534-004-1210-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute and chronic arsenic exposure results in toxicity in humans and causes many neurological and other manifestations. For the first time the present study reports that zinc decreases arsenic-induced apoptosis and also confirms a single report of apoptosis induced by arsenic in a neuronal cell line. Apoptosis measured by DEVD-caspase activity peaked between 10 muM and 20 muM of arsenic trioxide. Higher concentrations of arsenic up to 40 muM caused increasing cell death with diminishing DEVD-caspase activity. The beneficial effect of zinc was proportional to its concentration with a significant decrease in arsenic-induced DEVD-caspase activity at 50 muM and 75 muM zinc (P < 0.05). This finding may be of therapeutic benefit in people suffering from chronic exposure to arsenic from natural sources, a global problem especially relevant to millions of people on the Indian subcontinent.
引用
收藏
页码:707 / 713
页数:7
相关论文
共 43 条
[21]   EFFECTS OF SODIUM ARSENITE ON THE CYTOSKELETON AND CELLULAR GLUTATHIONE LEVELS IN CULTURED-CELLS [J].
LI, WD ;
CHOU, IN .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 114 (01) :132-139
[22]   Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death [J].
Lorenzo, HK ;
Susin, SA ;
Penninger, J ;
Kroemer, G .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (06) :516-524
[23]   Arsenic binding proteins from human lymphoblastoid cells [J].
Menzel, DB ;
Hamadeh, HK ;
Lee, E ;
Meacher, DM ;
Said, V ;
Rasmussen, RE ;
Greene, H ;
Roth, RN .
TOXICOLOGY LETTERS, 1999, 105 (02) :89-101
[24]   Correlation of tumor necrosis factor α (TNFα) with high Caspase 3-like activity in myelodysplastic syndromes [J].
Mundle, SD ;
Reza, S ;
Ali, A ;
Mativi, BY ;
Shetty, V ;
Venugopal, P ;
Gregory, SA ;
Raza, A .
CANCER LETTERS, 1999, 140 (1-2) :201-207
[25]   Inhibition of mitochondrial respiration - A novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism [J].
Pelicano, H ;
Feng, L ;
Zhou, Y ;
Carew, JS ;
Hileman, EO ;
Plunkett, W ;
Keating, MJ ;
Huang, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37832-37839
[26]  
PFEIFFER CJ, 1980, RES COMMUN CHEM PATH, V27, P587
[27]   Acute and chronic arsenic toxicity [J].
Ratnaike, RN .
POSTGRADUATE MEDICAL JOURNAL, 2003, 79 (933) :391-396
[28]   Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE) .2. Clinical efficacy and pharmacokinetics in relapsed patients [J].
Shen, ZX ;
Chen, GQ ;
Ni, JH ;
Li, XS ;
Xiong, SM ;
Qiu, QY ;
Zhu, J ;
Tang, W ;
Sun, GL ;
Yang, KQ ;
Chen, Y ;
Zhou, L ;
Fang, ZW ;
Wang, YT ;
Ma, J ;
Zhang, P ;
Zhang, TD ;
Chen, SJ ;
Chen, Z ;
Wang, ZY .
BLOOD, 1997, 89 (09) :3354-3360
[29]  
Shen ZY, 2003, INT J MOL MED, V11, P479
[30]   Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide [J].
Soignet, SL ;
Maslak, P ;
Wang, ZG ;
Jhanwar, S ;
Calleja, E ;
Dardashti, LJ ;
Corso, D ;
DeBlasio, A ;
Gabrilove, J ;
Scheinberg, DA ;
Pandolfi, PP ;
Warrell, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (19) :1341-1348